Mia's Feed
Medical News & Research

Diabetes Medication May Reduce Dementia Risk and Lower Mortality

Diabetes Medication May Reduce Dementia Risk and Lower Mortality

Share this article

New research indicates that metformin, a common diabetes drug, may lower the risk of dementia and early death, especially among overweight and obese adults. Discover the potential expanded benefits of this medication in recent studies.

2 min read

Recent research published in Diabetes, Obesity and Metabolism suggests that metformin, a common medication used to manage diabetes, could have protective effects against dementia and decrease the risk of early death. The study, conducted by investigators at Taipei Medical University, analyzed data from a large cohort of 452,777 adults with varying degrees of overweight and obesity over a period of ten years.

Within this population, there were 35,784 recorded cases of dementia and 76,048 deaths. Findings revealed that individuals who used metformin experienced significantly lower risks of developing dementia and dying from any cause compared to those who did not take the medication. The noted benefits were consistent across different categories of overweight and obesity severity, with metformin users showing an 8–12% reduction in dementia risk and a 26–28% reduction in all-cause mortality.

Lead researcher Dr. Chiehfeng Chen emphasized that while these results are promising, further studies are necessary to uncover the underlying mechanisms responsible for these protective effects. The study highlights the potential of metformin beyond its traditional use for managing blood sugar levels, suggesting it could play a role in strategies aimed at reducing dementia and mortality risks among overweight and obese populations.

This research adds to the growing body of evidence supporting the repurposing of existing medications for broader health benefits. More details of the study can be found in the publication "Protective Effect of Metformin Against Dementia in Patients With Obesity" in Diabetes, Obesity and Metabolism.

Source: https://medicalxpress.com/news/2025-08-diabetes-drug-dementia.html

Stay Updated with Mia's Feed

Get the latest health & wellness insights delivered straight to your inbox.

How often would you like updates?

We respect your privacy. Unsubscribe at any time.

Related Articles

Innovative 4D Optical Method Maps Airway Wall Elasticity During Bronchoscopy

A breakthrough 4D optical coherence tomography technique enables rapid, detailed mapping of airway wall elasticity during bronchoscopy, enhancing respiratory diagnostics and treatment planning.

Innovative Blood Test Enables Early Detection of Multiple Cancers via Cell-Free DNA

A novel blood test utilizing cell-free DNA analysis offers high accuracy in detecting multiple cancer types early, promising to improve diagnosis and treatment outcomes.

Harnessing Clinician Entrepreneurs to Boost Canada's Healthcare System and Economy

Emerging clinician entrepreneurs in Canada could revolutionize healthcare delivery and contribute to economic growth. Establishing specialized programs and policy reforms are key to unlocking this potential and driving innovation within the country's health system.

Expanding Mandatory Food Allergen Labels to Include High-Risk Emerging Allergens

Research advocates for expanding mandatory food allergen labeling to include high-risk emerging allergens such as goat's milk, buckwheat, and pine nuts to enhance consumer safety and prevent severe allergic reactions.